Which are the top stocks recommended by Market experts today? Which are top stocks recommended By Dhwani Patel for today. Confused about your portfolio? Which stock you  should buy or sell now? Watch more on ET Now
#stockstobuy #stockstosell #etnow #stocknews  #sharemarketnews #stockmarkets #stockmarkettoday #stockinnews #stocks
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3

Subscribe Now To Our Network Channels :-
Times Now  : http://goo.gl/U9ibPb
The NewsHour Debate : http://goo.gl/LfNgFF

To Stay Updated Download the Times Now App :-
Android Google Play :  https://goo.gl/zJhWjC
Apple App Store :  https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Top Stocks In Focus Today | Granules India, Birla Soft, Marksans Pharma | Dhwani Patel

Granules India receives US FDA approval for Esomeprazole Magnesium Delayed-Release Capsules, a generic version of AstraZeneca’s Nexium. The annual US market for the drug is $168M, and Granules now has 62 ANDA approvals from the US FDA. Indicated for short-term treatment of GERD and reduction of NSA…

Granules gets U.S. FDA nod for copy of AstraZeneca’s heartburn drug

The pharmaceutical raw-materials manufacturer has received approvals from the foreign drug regulators for its Jeedimetla and Bonthapally manufacturing facilities in Telangana

Granules India gains on nod from Japanese, Brazilian drug regulators

Block deals galore: Antfin to sell 3.6% stake in Paytm, Intl. Conveyors, Elpro Intl. acquire BSE shares, Reliance & Oberoi to manage 3 properties, Granules India gets ANVISA approval, Vedanta wins arbitration award, KPI Green Energy gets GEDA approval, TT signs MOU with U.P. Govt., Omega Seiki ties …

Stocks that will see action today: August 25, 2023

Here are the stocks to watch before going into trade today.

Stocks To Watch: Reliance Industries, Shoppers Stop, Bharti Airtel, Granules India, Bharat Electronics

Based on the OI percentage, 81 stocks were on the short-covering list. These included ITC, Granules India, Ipca Laboratories, Lupin, and Atul. A decrease in OI along with a price increase is an indication of short-covering.

Trade setup for Tuesday: Top 15 things to know before the opening bell

Motilal Oswal is bullish on Granules India recommended buy rating on the stock with a target price of Rs 370 in its research report dated August 09, 2023.

Buy Granules India; target of Rs 370: Motilal Oswal

Granules India’s net profit tanked 62.4 percent YoY to Rs 47.9 crore.

Granules India down over 4% as Q1 profit declines

On track to implement green project, backward integration.

Granules India Q1 Results Review - IT Issue Adversely Impacted Earnings: Motilal Oswal

Drugmaker Granules India reported consolidated net profit declined more than 62% year-on-year to nearly ₹48 crore during the June quarter on a 3% drop in revenue from operations to ₹985.516 crore.

IT security incident dents Granules Q1 net, revenue

This is Granules India’s fourth FDA audit since March with zero observations

Granules arm completes U.S. FDA’s PADE inspection

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Granules India Limited is a pharmaceutical company that manufactures finished dosages (FDs), pharmaceutical formulation intermediates (PFIs) and active pharmaceutical ingredients (APIs).